Drug Information

Drug General Information
Drug ID
D08YHA
Former ID
DNC008338
Drug Name
2,2-dimethyl-2H-benzo[g]chromene-5,10-dione
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529353]
Formula
C15H12O3
Canonical SMILES
CC1(C=CC2=C(O1)C(=O)C3=CC=CC=C3C2=O)C
InChI
1S/C15H12O3/c1-15(2)8-7-11-12(16)9-5-3-4-6-10(9)13(17)14(11)18-15/h3-8H,1-2H3
InChIKey
OWFHAMHRUCUSRM-UHFFFAOYSA-N
PubChem Compound ID
72734
Target and Pathway
Target(s) Indoleamine 2,3-dioxygenase Target Info Inhibitor [529353]
BioCyc Pathway Superpathway of tryptophan utilization
Tryptophan degradation
L-kynurenine degradation
Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
NAD de novo biosynthesis
KEGG Pathway Tryptophan metabolism
Metabolic pathways
African trypanosomiasis
NetPath Pathway TSLP Signaling Pathway
IL5 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
PathWhiz Pathway Tryptophan Metabolism
Reactome Tryptophan catabolism
WikiPathways Tryptophan metabolism
Metabolism of amino acids and derivatives
References
Ref 529353J Med Chem. 2008 Mar 27;51(6):1706-18. Epub 2008 Mar 5.Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Ref 529353J Med Chem. 2008 Mar 27;51(6):1706-18. Epub 2008 Mar 5.Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.